Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial is a research paper published in The Journal of Infectious Diseases (2023). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 75N91019D00024
National Institutes of Health
Grant: 75N91022F00007
Division of Microbiology and Infectious Diseases
Grant: 75N93021C00012
Biomedical Advanced Research and Development Authority
Grant: 75A50122C00008
NIH
Grant: 75N93021C00014
NIH
Grant: R01AI165818
BLRD VA
Grant: I01 BX000207
NIAID NIH HHS
Grant: UM1 AI148575
NCATS NIH HHS
Grant: UL1 TR002378
NIAID NIH HHS
Grant: UM1 AI148450
NIAID NIH HHS
Grant: UM1 AI148576
NIAID NIH HHS
Grant: UM1 AI148685
CLC NIH HHS
Grant: C0000008
NIAID NIH HHS
Grant: UM1 AI069432
Department of Health and Human Services
HHS
Office of the Assistant Secretary for Preparedness and Response
National Cancer Institute
US government
FWCI
0.50
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals